Switch theme
Sign up to access all valuation multiples
Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.
2010
23
LTM Revenue $0.2M
LTM EBITDA -$5.8M
$77.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Amoeba has a last 12-month revenue (LTM) of $0.2M and a last 12-month EBITDA of -$5.8M.
In the most recent fiscal year, Amoeba achieved revenue of n/a and an EBITDA of -$5.5M.
Amoeba expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amoeba valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $0.2M | XXX | n/a | XXX | XXX | XXX |
| Gross Profit | -$0.1M | XXX | -$1.7M | XXX | XXX | XXX |
| Gross Margin | -43% | XXX | n/a | XXX | XXX | XXX |
| EBITDA | -$5.8M | XXX | -$5.5M | XXX | XXX | XXX |
| EBITDA Margin | -3584% | XXX | n/a | XXX | XXX | XXX |
| EBIT | -$6.7M | XXX | -$6.4M | XXX | XXX | XXX |
| EBIT Margin | -4137% | XXX | n/a | XXX | XXX | XXX |
| Net Profit | -$8.0M | XXX | -$7.4M | XXX | XXX | XXX |
| Net Margin | -4915% | XXX | n/a | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $12.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Amoeba's stock price is EUR 1 (or $1).
Amoeba has current market cap of EUR 57.7M (or $64.8M), and EV of EUR 69.3M (or $77.8M).
See Amoeba trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $77.8M | $64.8M | XXX | XXX | XXX | XXX | $-0.15 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Amoeba has market cap of $64.8M and EV of $77.8M.
Amoeba's trades at n/a EV/Revenue multiple, and -14.2x EV/EBITDA.
Equity research analysts estimate Amoeba's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Amoeba has a P/E ratio of -8.1x.
See valuation multiples for Amoeba and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $64.8M | XXX | $64.8M | XXX | XXX | XXX |
| EV (current) | $77.8M | XXX | $77.8M | XXX | XXX | XXX |
| EV/Revenue | 478.4x | XXX | n/a | XXX | XXX | XXX |
| EV/EBITDA | -13.3x | XXX | -14.2x | XXX | XXX | XXX |
| EV/EBIT | -11.6x | XXX | -12.2x | XXX | XXX | XXX |
| EV/Gross Profit | -1116.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | -8.1x | XXX | -8.7x | XXX | XXX | XXX |
| EV/FCF | -8.2x | XXX | -14.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAmoeba's last 12 month revenue growth is 1199%
Amoeba's revenue per employee in the last FY averaged n/a, while opex per employee averaged $0.2M for the same period.
Amoeba's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Amoeba's rule of X is -587% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Amoeba and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1199% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | -3584% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | -2% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -587% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Hydratec Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| Brazil Potash | XXX | XXX | XXX | XXX | XXX | XXX |
| House of Agriculture | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers & Chemicals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amoeba acquired XXX companies to date.
Last acquisition by Amoeba was XXXXXXXX, XXXXX XXXXX XXXXXX . Amoeba acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Amoeba founded? | Amoeba was founded in 2010. |
| Where is Amoeba headquartered? | Amoeba is headquartered in France. |
| How many employees does Amoeba have? | As of today, Amoeba has 23 employees. |
| Is Amoeba publicy listed? | Yes, Amoeba is a public company listed on PAR. |
| What is the stock symbol of Amoeba? | Amoeba trades under ALMIB ticker. |
| When did Amoeba go public? | Amoeba went public in 2015. |
| Who are competitors of Amoeba? | Similar companies to Amoeba include e.g. Fertiglobe, Hydratec Industries, Brazil Potash, House of Agriculture. |
| What is the current market cap of Amoeba? | Amoeba's current market cap is $64.8M |
| What is the current revenue of Amoeba? | Amoeba's last 12 months revenue is $0.2M. |
| What is the current revenue growth of Amoeba? | Amoeba revenue growth (NTM/LTM) is 1199%. |
| What is the current EV/Revenue multiple of Amoeba? | Current revenue multiple of Amoeba is 478.4x. |
| Is Amoeba profitable? | Yes, Amoeba is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Amoeba? | Amoeba's last 12 months EBITDA is -$5.8M. |
| What is Amoeba's EBITDA margin? | Amoeba's last 12 months EBITDA margin is -3584%. |
| What is the current EV/EBITDA multiple of Amoeba? | Current EBITDA multiple of Amoeba is -13.3x. |
| What is the current FCF of Amoeba? | Amoeba's last 12 months FCF is -$9.5M. |
| What is Amoeba's FCF margin? | Amoeba's last 12 months FCF margin is -5855%. |
| What is the current EV/FCF multiple of Amoeba? | Current FCF multiple of Amoeba is -8.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
